Related Experiment Video
Updated: Dec 6, 2025

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
No Decrease in Infection Rate with the Use of Local Vancomycin Powder After Partial Hip Replacement in Elderly
H Yener Erken1, Gurdal Nusran1, Doğaç Karagüven2
1Orthopaedics and Traumatology, Canakkale Onsekiz Mart University, Canakkale, TUR.
Local vancomycin powder did not reduce surgical site infections in elderly hip replacement patients. This study found no significant difference in infection rates between vancomycin-treated and non-treated groups.
Area of Science:
- Orthopedic Surgery
- Infectious Disease Prevention
- Pharmacology
Background:
- Surgical site infections (SSIs) are a significant concern, especially in elderly patients with comorbidities undergoing hip replacement.
- Reducing SSIs is crucial for improving patient outcomes and decreasing healthcare costs.
Purpose of the Study:
- To evaluate the efficacy of local intra-wound vancomycin powder (VP) in preventing SSIs after partial hip replacement.
- To assess VP's effectiveness in elderly patients with comorbidities undergoing treatment for intertrochanteric (ITF) or femoral neck fractures (FNF).
Main Methods:
- Retrospective review of 93 patients undergoing partial hip replacement for ITF or FNF.
- Patients were divided into two groups: standard systemic prophylaxis (cefazolin) and standard prophylaxis plus 1g of intra-wound vancomycin powder.
- Inclusion criteria: age 64+ with one or more comorbidities.
Main Results:
- Overall SSI rate was 6.4% (6 out of 93 patients).
- SSI rate in the vancomycin-treated group was 5.7%, and 6.9% in the non-treated group (p=0.498), showing no statistically significant difference.
- Higher SSI incidence was observed in patients with post-operative intensive care unit (ICU) follow-up.
Conclusions:
- Local intra-wound vancomycin powder application was ineffective in reducing SSIs after partial hip replacement in elderly patients with comorbidities.
- Further research may be needed to explore alternative strategies for SSI prevention in this high-risk population.
More Related Videos
Related Concept Videos
Drug Dosing: Geriatric Patients
Antimicrobial Effectiveness
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

